News

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that the…
Read More...

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo…
Read More...

PacBio and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The…
Read More...

GenScript ProBio announced the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province. The…
Read More...

Arbutus Biopharma Corporation, X-Chem, Inc. (X-Chem) and Proteros biostructures GmbH (Proteros) announced that Arbutus Biopharma has identified several molecules that inhibit the…
Read More...

Telix Pharmaceuticals Limited announces that it has entered into an exclusive commercial distribution agreement with Madrid-based NUCLIBER S.A. Spain (NUCLIBER) for Telix’s prostate…
Read More...

Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an anthelmintic, in combination with dexamethasone, an…
Read More...

AstraZeneca has entered into a new global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-LRX. …
Read More...

-      Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets.…
Read More...

Recursion a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation,…
Read More...

Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, and CEPI, the Coalition for Epidemic Preparedness…
Read More...

The European Medicines Agency (EMA) has accepted for review under an accelerated assessment procedure the Marketing Authorization Application (MAA) for olipudase alfa, Sanofi’s…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant…
Read More...

Merck, known as MSD outside the United States and Canada, announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 (MK-8591-024) Phase 3 clinical studies…
Read More...

Quantum Genomics, a biopharmaceutical company specializing in the development of first-in-class drugs directly targeting the brain to treat complex/resistant hypertension, has announced…
Read More...

Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therapy of KRAS G12C inhibitor JAB-21822 and Cetuximab injection from the…
Read More...

NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation, custom synthesis, flow chemistry, and process development has…
Read More...

National Resilience, Inc. (Resilience), a technology focused manufacturing company dedicated to broadening access to complex medicines, announced the acquisition of SwiftScale…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for…
Read More...

Valneva SE confirmed that the European Medicines Agency (EMA) has started a rolling review of VLA2001, its whole-virus inactivated, adjuvanted COVID-19 vaccine candidate. Valneva…
Read More...